RAGE inhibitor (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RAGE inhibitor (investigational), covering 2025-12-24 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer [Phase 1, Phase 2]